Detalles de la búsqueda
1.
A Phase 2a Randomized, Double-Blind, Dose-Optimizing Study to Evaluate the Immunogenicity and Safety of a Bivalent DNA Vaccine for Hemorrhagic Fever with Renal Syndrome Delivered by Intramuscular Electroporation.
Vaccines (Basel)
; 8(3)2020 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32664486
2.
A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
Clin Microbiol Infect
; 20 Suppl 5: 110-7, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24447183
Resultados
1 -
2
de 2
1
Próxima >
>>